NCT03194893 2026-02-20A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive CancerHoffmann-La RochePhase 3 Active not recruiting200 enrolled
NCT03780517 2023-10-30Safety, Efficacy, and Tolerability of BOS172738 in Patients With Advanced Rearranged During Transfection (RET) Gene-Altered TumorsBoston PharmaceuticalsPhase 1 Completed117 enrolled